{"id":"https://openalex.org/W2064398161","doi":"https://doi.org/10.1158/1538-7445.am2014-1410","title":"Abstract 1410: Gnaq/11 mutant uveal melanoma is susceptible to Brd4 inhibition by JQ1","display_name":"Abstract 1410: Gnaq/11 mutant uveal melanoma is susceptible to Brd4 inhibition by JQ1","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W2064398161","doi":"https://doi.org/10.1158/1538-7445.am2014-1410","mag":"2064398161"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2014-1410","doi":"https://doi.org/10.1158/1538-7445.am2014-1410","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-1410","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026962347","display_name":"Grazia Ambrosini","orcid":"https://orcid.org/0000-0002-3051-362X","observed_orcids":["https://orcid.org/0000-0002-3051-362X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grazia Ambrosini","raw_affiliation_strings":["Mem. Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mem. Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":["Mem. Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mem. Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"19_Supplement","first_page":"1410","last_page":"1410"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.9679999947547913},{"id":"https://openalex.org/keywords/gnaq-mutation","display_name":"GNAQ mutation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/gna11-mutation","display_name":"GNA11 mutation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.890999972820282},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.7919999957084656},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.8299999833106995},{"id":"https://openalex.org/keywords/myc-amplification","display_name":"MYC amplification","score":0.8830000162124634},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9449999928474426},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8669999837875366},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8840000033378601},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.7480000257492065},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.734000027179718},{"id":"https://openalex.org/keywords/xiap","display_name":"XIAP","score":0.6340000033378601},{"id":"https://openalex.org/keywords/e2f1","display_name":"E2F1","score":0.6620000004768372},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6890000104904175},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7770000100135803},{"id":"https://openalex.org/keywords/chromatin-regulators","display_name":"chromatin regulators","score":0.7020000219345093},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.3319999873638153}],"concepts":[{"id":"https://openalex.org/C2779176653","wikidata":"https://www.wikidata.org/wiki/Q18026236","display_name":"GNAQ","level":4,"score":0.971297025680542},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.766566276550293},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7000788450241089},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5557674765586853},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.4984121322631836},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49365004897117615},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.45522603392601013},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.445074200630188},{"id":"https://openalex.org/C33195913","wikidata":"https://www.wikidata.org/wiki/Q20970121","display_name":"XIAP","level":5,"score":0.4386013150215149},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3795856833457947},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3343470096588135},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.3267737030982971},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3189498484134674},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.22142398357391357},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.17083898186683655},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.07733011245727539},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07473602890968323},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.06903624534606934},{"id":"https://openalex.org/C98424977","wikidata":"https://www.wikidata.org/wiki/Q25805","display_name":"Caspase","level":4,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2014-1410","doi":"https://doi.org/10.1158/1538-7445.am2014-1410","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-1410","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1596286866","https://openalex.org/W2194517235","https://openalex.org/W2498883272","https://openalex.org/W3181751697","https://openalex.org/W3083742395","https://openalex.org/W4297182267","https://openalex.org/W2150772498","https://openalex.org/W1964497109","https://openalex.org/W2978910850","https://openalex.org/W2090787537"],"abstract_inverted_index":{"Abstract":[0],"Uveal":[1,24],"melanoma":[2,25,301,321,335],"(UM)":[3],"represents":[4],"the":[5,11,37,55,58,95,109,122,130,174,188,196,208,233,241,248,258,274,283,310,347,352],"most":[6,175],"common":[7],"intraocular":[8],"malignancy":[9],"in":[10,31,84,134,239,257,270,272,281,291,295],"United":[12],"States,":[13],"and":[14,33,46,62,90,160,218,229,252,277],"there":[15],"are":[16,49,68],"no":[17],"effective":[18],"treatments":[19],"for":[20,104,319,355],"this":[21],"aggressive":[22],"disease.":[23],"is":[26,78,82,91,336],"characterized":[27,50],"by":[28,51,94,121,187,341],"oncogenic":[29],"mutations":[30,147],"Gnaq":[32,303],"Gna11,":[34],"which":[35,67,77,214],"activate":[36],"mitogen-activated":[38],"protein":[39,235,250],"kinase":[40],"pathway":[41],"(MAPK).":[42],"Furthermore,":[43,286],"both":[44],"primary":[45],"metastatic":[47],"UM":[48,139],"genetic":[52],"abnormalities,":[53],"including":[54,142],"amplification":[56,158,166,201],"of":[57,64,87,117,124,132,137,183,211,221,299,346,351],"chromosomal":[59],"arm":[60],"8q":[61],"monosomy":[63],"chromosome":[65],"3,":[66],"significantly":[69],"associated":[70],"with":[71,145,156,191,288,302,322],"poor":[72],"prognosis.":[73],"The":[74,169],"oncogene":[75],"MYC,":[76],"located":[79],"on":[80],"8q24.1,":[81],"amplified":[83,192],"nearly":[85],"70%":[86],"uveal":[88,300,320,334],"melanoma,":[89],"also":[92,206,246],"regulated":[93],"MAPK":[96],"pathway.":[97],"Chromatin":[98],"regulators":[99],"have":[100],"become":[101],"attractive":[102],"targets":[103],"cancer":[105],"therapy.":[106],"In":[107],"particular,":[108],"BET-bromodomain":[110],"inhibitor":[111],"JQ1":[112,133,184,212,245,289,313],"has":[113],"shown":[114],"selective":[115],"inhibition":[116,179,340],"c-Myc":[118,222],"expression,":[119],"followed":[120,186],"suppression":[123,220],"c-Myc-dependent":[125],"target":[126],"genes.":[127],"We":[128,205],"examined":[129,207],"effects":[131,210],"a":[135,153,216,266,315],"panel":[136],"8":[138],"cell":[140,143,154,189,242,267,275],"lines,":[141],"lines":[144,276],"Gnaq/Gna11":[146,170,259,323],"(92.1,":[148],"Omm1.3,":[149],"Mel270,":[150],"Mel202,":[151],"Omm1),":[152],"line":[155,190],"MYC":[157,193],"(Mel290),":[159],"cells":[161,172,197],"without":[162,198],"either":[163],"mutation":[164,199],"or":[165,200],"(C918,":[167],"Mel285).":[168],"mutant":[171,260,284,333],"were":[173,237],"sensitive":[176],"to":[177,338],"growth":[178],"at":[180],"nanomolar":[181],"concentrations":[182],"(IC50=200nM),":[185],"(IC50=1\u03bcM),":[194],"while":[195,231],"exhibited":[202],"little":[203],"inhibition.":[204],"biochemical":[209],"treatment,":[213],"caused":[215],"dose-":[217],"time-dependent":[219],"as":[223,225],"well":[224],"survivin,":[226],"XIAP,":[227],"ERK1":[228],"E2F1,":[230],"p21and":[232],"pro-apoptotic":[234],"Bim":[236],"induced":[238,253],"all":[240,273],"lines.":[243],"Interestingly,":[244],"suppressed":[247],"anti-apoptotic":[249],"Bcl-xL":[251],"PARP":[254],"cleavage":[255],"only":[256],"cells.":[261,285],"Flow":[262],"cytometric":[263],"analysis":[264],"indicated":[265],"cycle":[268],"arrest":[269],"G1":[271],"an":[278],"apoptotic":[279],"population":[280],"sub-G1in":[282],"treatment":[287],"resulted":[290],"significant":[292],"antitumor":[293],"activity":[294],"mouse":[296],"xenograft":[297],"models":[298],"mutation.":[304],"All":[305],"together,":[306],"these":[307],"observations":[308],"support":[309],"evidence":[311],"that":[312],"represent":[314],"promising":[316],"therapeutic":[317],"approach":[318],"mutations.":[324],"Citation":[325],"Format:":[326],"Grazia":[327],"Ambrosini,":[328],"Gary":[329],"K.":[330],"Schwartz.":[331],"Gnaq/11":[332],"susceptible":[337],"Brd4":[339],"JQ1.":[342],"[abstract].":[343],"In:":[344],"Proceedings":[345],"105th":[348],"Annual":[349],"Meeting":[350],"American":[353],"Association":[354],"Cancer":[356,367],"Research;":[357],"2014":[358],"Apr":[359],"5-9;":[360],"San":[361],"Diego,":[362],"CA.":[363],"Philadelphia":[364],"(PA):":[365],"AACR;":[366],"Res":[368],"2014;74(19":[369],"Suppl):Abstract":[370],"nr":[371],"1410.":[372],"doi:10.1158/1538-7445.AM2014-1410":[373]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}